ResearcherThe University of SydneyNo recent work listed
Matthew H. Wong
Matched on ORCID iD 0000-0003-4503-2922; OpenAlex author ID A5103068597. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper
Papers 3
- Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume r… Co-author DOI 10.1016/j.ejso.2017.06.012↗
- Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.neo.2016.06.001↗
- Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-13-3377↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nick Pavlakis · 3 shared papers, 2014–2017 · strength 0.17
- Paper Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Duct… DOI 10.1016/j.neo.2016.06.001↗
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Paper Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal a… DOI 10.1158/1078-0432.ccr-13-3377↗
- Aiqun Xue · 2 shared papers, 2014–2016 · strength 0.12
- Paper Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Duct… DOI 10.1016/j.neo.2016.06.001↗
- Paper Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal a… DOI 10.1158/1078-0432.ccr-13-3377↗
- Ross C. Smith · 2 shared papers, 2014–2016 · strength 0.12
- Paper Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Duct… DOI 10.1016/j.neo.2016.06.001↗
- Paper Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal a… DOI 10.1158/1078-0432.ccr-13-3377↗
- Jaswinder Singh Samra · 2 shared papers, 2014–2017 · strength 0.10
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Paper Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal a… DOI 10.1158/1078-0432.ccr-13-3377↗
- Anthony James Gill · 2 shared papers, 2014–2017 · strength 0.10
- Paper Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic … DOI 10.1016/j.ejso.2017.06.012↗
- Paper Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal a… DOI 10.1158/1078-0432.ccr-13-3377↗
- Stephen John Clarke · 1 shared paper, 2017 · strength 0.05
- Malinda Itchins · 1 shared paper, 2017 · strength 0.05
- Terence C. Chua · 1 shared paper, 2017 · strength 0.05
- Christopher Bahdah Nahm · 1 shared paper, 2017 · strength 0.05
- George Hruby · 1 shared paper, 2017 · strength 0.05
- Anubhav Mittal · 1 shared paper, 2017 · strength 0.05
- Sohel M. Julovi · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.